Sponsor content
342 result(s) found, displaying 151 to 160
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Budesonide / glycopyrronium / formoterol
-
Prescription medicine decision summaryTGA Decision: Saphnelo (anifrolumab) is approved to treat adult patients with active systemic lupus erythematosus (SLE).
-
Australian Public Assessment Report (AusPAR)Forxiga (dapagliflozin) has been approved for reducing the risk of progressive decline in kidney function in adults with
proteinuric chronic kidney disease. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRICANYL TURBUHALER terbutaline sulfate 400 microgram powder for inhalation dry powder inhaler.
-
-
Designation or determinationProvisional determination
-
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Australian Public Assessment Report (AusPAR)New AusPAR for EVUSHELD (tixagevimab and cilgavimab) for pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years older
-
Prescription medicine decision summaryTGA decision: Evusheld (tixagevimab/cilgavimab) is approved for the treatment of pre-exposure prophylaxis of COVID-19.